Adagarasib Patient Medication Guide

Adagrasib is an oral drug targeting advanced tumors associated with KRAS G12C mutations. As a targeted therapy, it could potentially lead to new treatment options for patients with this specific genetic mutation. However, patients need to closely follow their doctor's recommendations when using adagrasib and understand how to use and administer the drug correctly. Here are Medication Guidelines for patients:

1. Physician's orders and prescriptions: Before starting to use adagrasib, patients should carefully read and understand the instructions for use according to the doctor's instructions. Adagrasiib is usually administered orally at 600mg twice daily. Patients should use the medicine strictly in accordance with the doctor's instructions and do not change the dosage or stop using it on their own, so as not to affect the treatment effect.

2. Dosing time and frequency: Adagrasiib is usually taken after meals and should be taken at the same time every day to ensure stable drug blood concentration. If the patient forgets to take a dose, refill the dose as soon as possible without realizing it, but if the next dose is only a few hours away, the dose should be skipped to avoid an overdose.

3. Diet and drug interactions: Patients should avoid foods or drugs that may interact with adagrasib. Some foods or medications may affect the absorption of adagrasib or make it less effective. Before starting adagrasib, tell your doctor about all medications, supplements and supplements you are taking to avoid possible interactions.

4. Adverse reactions and side effects: Adagrasiib may cause some adverse reactions and side effects, including but not limited to nausea, vomiting, diarrhea, fatigue, rash, etc. If the patient develops any symptoms of discomfort while using adagrasib, he or she should inform the doctor in time so that the treatment plan can be adjusted or corresponding supportive treatment can be provided.

5. Regular follow-up and monitoring: During the use of adagrasib, patients should undergo regular follow-up and monitoring. This includes imaging evaluation of the tumor, biomarker testing, and assessment of physical symptoms and adverse effects. This helps doctors adjust treatment plans in a timely manner to ensure patients get the best treatment results.

6. Lifestyle and psychological support: During treatment with adagrasib, patients should maintain a healthy lifestyle, including good eating habits, moderate exercise, and adequate rest. In addition, patients may face emotional and psychological stress, and it is recommended that they actively seek psychological support or join a support group for support and encouragement.

7. Disposal of leftover and expired drugs;Patients should properly dispose of leftover and expired drugs. Expired medicines may lose effectiveness or produce harmful substances and should be disposed of in the correct manner, such as sending them to pharmacies or medical institutions for recycling.

Adagrasib, as a targeted therapy, provides a new treatment option for patients with advanced tumors suffering fromKRAS G12C mutations. Patients should strictly abide by the doctor's instructions and medication guidelines, conduct regular follow-up and monitoring, and promptly report any adverse reactions or symptoms. By using and managing medications correctly, patients can maximize the effectiveness of their treatments and improve their quality of life.